Meyer Colin John

Avg. Two Year Performance

331% Avg. Purchase Return
108% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return68%122%43%63%331%
Purchase Success Rate1 of 11 of 11 of 11 of 11 of 1
Average Sale Return20%27%26%20%0%
Sale Success Rate2 of 22 of 21 of 21 of 20 of 2

Reata Pharmaceuticals Inc

Other » Other

Chief Innovation Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--